Use of Circulating Tumor DNA (ctdna) to Affect the Adjuvant or Post-Adjuvant Treatment of Patients with Stage III and High-Risk Stage II Resected Colon Cancer: the ERASE-CRC Project by GONO.
Journal of Clinical Oncology(2024)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined